CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
Neurona Therapeutics |
Dr. Cory R Nicholas |
Therapeutic Translational Research Projects |
Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy. |
$3,828,714 |
City of Hope, Beckman Research Institute |
Lei Tian |
Therapeutic Translational Research Projects |
Targeting pancreatic cancer with Allogeneic Off-the-Shelf PSCA-CAR NK cells |
$0 |
University of California, Los Angeles |
Dr. Lili Yang |
Therapeutic Translational Research Projects |
Combating Ovarian Cancer with Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy |
$5,601,600 |
Stanford University |
Natalia Gomez-Ospina |
Therapeutic Translational Research Projects |
Toward a Cure for Gaucher Disease Type 1: Autologous Transplantation of Genome Edited Hematopoietic Stem Cells |
$4,696,296 |
Replay Holdings, Inc |
Anthony Conway |
Therapeutic Translational Research Projects |
Hypoimmunogenic iPSC-derived TCR-NK cells for oncology |
$0 |
AcuraStem Incorporated |
Mr. Samuel V. Alworth MS, MBA |
Therapeutic Translational Research Projects |
Development of AS-241, an UNC13A Targeting Antisense Oligonucleotide (ASO) Treatment for ALS, for IND-enabling Studies |
$4,012,325 |
Axent Biosciences Inc. |
Abhay Joshi |
Therapeutic Translational Research Projects |
A high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation |
$3,999,241 |
University of California, Los Angeles |
Dr. Gerald Lipshutz DDS, MD, MS |
Therapeutic Translational Research Projects |
Development of a Gene Therapy for Treatment of Guanidinoacetate Methyltransferase Deficiency-Translating In Vivo Proof of Concept to Support a Pre-IND |
$5,145,825 |
Ray Therapeutics, INC |
Paul Bresge |
Therapeutic Translational Research Projects |
Optogenetic Therapy for Treatment of Geographic Atrophy |
$3,998,930 |
University of California, San Francisco |
Sarah Monica Knox |
Therapeutic Translational Research Projects |
Neurogenic hydrogel stimulation of stem cells to regenerate radiation-damaged salivary glands |
$2,312,021 |
Siren Biotechnology, Inc. |
Dr Nicole K Paulk |
Therapeutic Translational Research Projects |
Development of an AAV gene therapy immunotherapy for the treatment of glioblastoma |
$3,997,919 |
Cedars-Sinai Medical Center |
Dr. Ahmed Gamal Ibrahim |
Therapeutic Translational Research Projects |
Noncoding RNA drug TY1 as a therapeutic candidate for scleroderma and systemic sclerosis |
$2,590,224 |
University of California, San Diego |
Dr Karen Christman |
Therapeutic Translational Research Projects |
Pro-regenerative infusible ECM biomaterial for treating acute myocardial infarction |
$4,353,438 |
University of California, Los Angeles |
Zulema Romero Garcia |
Therapeutic Translational Research Projects |
Adenine Base Editing for Autologous Hematopoietic Stem Cell Gene Therapy of CD3δ SCID |
$5,966,928 |
University of California, Los Angeles |
Dr. Donald B. Kohn PhD |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Editing for X-linked Agammaglobulinemia (XLA) |
$4,304,883 |
University of California, San Diego |
Dr. Eric D. Adler MD |
Therapeutic Translational Research Projects |
Ex Vivo Modified Hematopoietic Stem Cells to Treat Danon Disease |
$5,180,389 |
University of California, Los Angeles |
Dr. Gerald Lipshutz DDS, MD, MS |
Therapeutic Translational Research Projects |
Development of a Gene Therapy for the Treatment of Arginase Deficiency – Translating from Proof of Concept to Support Pre-IND Meeting |
$5,266,504 |
City of Hope, Beckman Research Institute |
Dr Michael A. Caligiuri |
Therapeutic Translational Research Projects |
Targeting multiple myeloma with BCMA-CAR NK cells expressing a GPRC5D-NKG2D bispecific antibody |
$6,036,001 |
University of California, Los Angeles |
Anthony J Aldave |
Therapeutic Translational Research Projects |
AAV Gene Therapy for Treating Congenital Hereditary Endothelial Dystrophy associated with Biallelic SLC4A11 Mutations |
$4,338,166 |
ImmunoVec |
Luke Riggan |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Therapy for Wiskott Aldrich Syndrome |
$3,999,899 |
BrainXell Therapeutics |
Maria Daniela Cirnaru |
Therapeutic Translational Research Projects |
Development of Autologous Cell Replacement Therapy for Parkinson’s Disease: Path to Personalized Treatment |
$3,841,110 |
University of California, Los Angeles |
Dr. Sophie X Deng |
Therapeutic Translational Research Projects |
Extracellular Vesicle-Based Therapy for Corneal Scars |
$5,779,276 |
University of California, Los Angeles |
Dr. Scott G Kitchen |
Therapeutic Translational Research Projects |
Hematopoietic Stem/Progenitor Cell-Based Chimeric Antigen Receptor Gene Therapy for HIV Infection |
$6,140,723 |
Rejuvenation Technologies, Inc. |
John Ramunas |
Therapeutic Translational Research Projects |
Telomerase mRNA for short telomere related pulmonary fibrosis |
$3,984,942 |
University of Southern California |
Dr. Rongfu Wang |
Therapeutic Translational Research Projects |
Novel T cell receptor-STEM T cell immunotherapy in lung cancer |
$5,689,540 |
Stanford University |
Walter Park |
Therapeutic Translational Research Projects |
Enhanced Autologous Pancreatic Islet Transplantation and Survival for Diabetes Mellitus Therapy |
$6,054,165 |
University of California, Irvine |
Jianhua Yu |
Therapeutic Translational Research Projects |
Specific Targeting Hypoxia Metastatic Breast Tumor with Allogeneic Off-the-Shelf Anti-EGFR CAR NK Cells Expressing an ODD domain of HIF-1α |
$4,769,410 |
VxBiosciences inc. |
Dr. Christina Chuong |
Therapeutic Translational Research Projects |
Escape-Resistant Oligonucleotide Therapy (ONT) for Cytomegalovirus (CMV) Disease in Hematopoietic Stem-Cell and Solid-Organ Transplant Patients |
$730,000 |
City of Hope, Beckman Research Institute |
Lei Tian |
Therapeutic Translational Research Projects |
Specific Targeting Hypoxia Metastatic Breast Tumor with Allogeneic Off-the-Shelf Anti-EGFR CAR NK Cells Expressing an ODD domain of HIF-1α |
$1,266,592 |
Mahzi Therapeutics |
Dr. Allyson Berent |
Therapeutic Translational Research Projects |
Development of a Gene Therapy for the Treatment of Pitt Hopkins Syndrome (PHS) – Translating from Animal Proof of Concept to Support Pre-IND Meeting |
$3,800,760 |
University of California, Davis |
Dr. William J Murphy |
Therapeutic Translational Research Projects |
Overcoming resistance to standard CD19-targeted CAR T using a novel triple antigen targeted vector |
$3,869,061 |
University of California, San Diego |
Stephanie Cherqui |
Therapeutic Translational Research Projects |
CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia |
$4,846,579 |
University of Southern California |
Preet M Chaudhary |
Therapeutic Translational Research Projects |
Next generation affinity-tuned CAR for prostate cancer |
$5,805,144 |
University of California, Los Angeles |
Dr. Donald B. Kohn PhD |
Therapeutic Translational Research Projects |
Autologous MPO Knock-Out Hematopoietic Stem and Progenitor Cells for Pulmonary Arterial Hypertension |
$4,751,297 |
Ray Therapeutics, INC |
Paul Bresge |
Therapeutic Translational Research Projects |
Optogenetic therapy for treating retinitis pigmentosa and other inherited retinal diseases |
$3,999,553 |
University of California, Irvine |
Dr. Aileen J Anderson |
Therapeutic Translational Research Projects |
A human neural stem cell therapeutic candidate for the treatment of chronic cervical spinal cord injury |
$4,950,024 |
University of California, San Francisco |
Arun P Wiita |
Therapeutic Translational Research Projects |
CD72 nanoCARs for the treatment of refractory pediatric B-cell acute lymphoblastic leukemia |
$3,330,801 |
MyoGene Bio LLC |
Dr Courtney Young |
Therapeutic Translational Research Projects |
Development of MyoDys45-55, a gene editing therapy for Duchenne muscular dystrophy |
$3,400,000 |
Immusoft Corporation |
Dr Robert Hayes |
Therapeutic Translational Research Projects |
MPS II: Plasma cell delivery of iduronate sulfatase |
$3,994,676 |
Regencor, Inc. |
PILAR RUIZ-LOZANO |
Therapeutic Translational Research Projects |
IND-enabling Studies of Wearable Evolve-FSTL1 for Cardiac Regeneration after MI |
$3,923,191 |
University of California, San Francisco |
Dr. Hideho Okada |
Therapeutic Translational Research Projects |
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma |
$4,556,536 |
ImmunoVec |
Luke Riggan |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Therapy for IPEX Syndrome |
$3,551,332 |
University of California, Los Angeles |
Dr. Arjun Deb |
Therapeutic Translational Research Projects |
Targeting stromal progenitors to prevent the development of heart failure |
$4,714,824 |
Palo Alto Veterans Institute for Research |
Irene Lorenzo Llorente |
Therapeutic Translational Research Projects |
Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia |
$5,149,913 |
University of California, Los Angeles |
Dr. Irene L. Llorente |
Therapeutic Translational Research Projects |
Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia |
$707,754 |
Juvena Therapeutics Inc. |
Jeremy D O’Connell |
Therapeutic Translational Research Projects |
Clinical Translation of hESC-derived protein therapy that positively regulates the regenerative capacity of post-natal muscle for treating DM1 |
$3,906,376 |
University of California, Los Angeles |
Cristina Puig Saus |
Therapeutic Translational Research Projects |
CAR-Tnm cell therapy for melanoma targeting TYRP-1 |
$5,904,462 |
University of California, Los Angeles |
Dr. Lili Yang |
Therapeutic Translational Research Projects |
HSC-Engineered Off-The-Shelf CAR-iNKT Cell Therapy for Multiple Myeloma |
$5,281,199 |
University of California, San Francisco |
Dr. Hideho Okada |
Therapeutic Translational Research Projects |
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma |
$525,000 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Evan Y. Snyder |
Therapeutic Translational Research Projects |
Human Neural Stem Cells (hNSCs) for neuroprotection in perinatal hypoxic-ischemic brain injury (HII)-Pre-IND-enabling Studies |
$4,963,684 |